Aug 26, 2021 9:30am EDT Rite Aid, in Partnership with the U.S. Department of Health and Human Services, BioReference Laboratories and New York State, Announces ‘Back to School’ COVID-19 Testing Program
Aug 16, 2021 9:55am EDT BioReference Laboratories Acquires U.S. Ariosa Centralized Laboratory Prenatal Testing Business
Jul 29, 2021 4:05pm EDT OPKO Health Reports 2021 Second Quarter Business Highlights and Financial Results
Jul 12, 2021 8:00am EDT OPKO Health Licenses Oligonucleotide Therapeutics Platform to CAMP4 Therapeutics
Jun 22, 2021 7:39am EDT BioReference Laboratories Announces First COVID-19 Testing Program for Cruise Industry
Jun 21, 2021 8:03am EDT OPKO Health to Develop and Commercialize RAYALDEE® in Greater China with Nicoya Therapeutics
Jun 17, 2021 7:00am EDT OPKO Health Announces Sale of its Sterile Fill and Finish Manufacturing Facility in Ireland